Medical Simulation Market worth $7.23 billion by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., Feb. 9, 2026 /PRNewswire/ — According to MarketsandMarkets, the Medical Simulation Market is projected to grow from about USD 3.50 billion in 2025 to USD 7.23 billion by 2030, at a CAGR of 15.6%.

Browse 350 market data Tables and 55 Figures spread through 380 Pages and in-depth TOC on “Medical Simulation Market – Global Forecast to 2030”

Medical Simulation Market Size & Forecast:

• Market Size Available for Years: 2024–2030
• 2025 Market Size: USD 3.50 billion
• 2030 Projected Market Size: USD 7.23 billion
• CAGR (2026–2031): 15.6%

Medical Simulation Market Trends & Insights:

• By offering, the web-based simulation segment is expected to register the highest CAGR of 17.3% during the forecast period.
• By technology, the virtual patient simulation segment is expected to register the highest CAGR of 16.6% during the forecast period.
• North America to dominate the market with a share of 42.6% in 2024.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1156 

The medical simulation market is growing as demand rises for safer, more effective clinical training and skills development. Government investments and healthcare education initiatives are driving the adoption of simulation technologies in hospitals and academic institutions, while increased private funding is accelerating innovation. For example, in January 2024, Oxford Medical Simulation recently raised USD 12.6 million in Series A funding to expand its VR-based training platform, underscoring strong market confidence and growth potential.

The medical simulation market benefits from supportive regulatory oversight that promotes safe, standardized clinical training. Regulatory and accreditation bodies such as the US Food and Drug Administration, the European Medicines Agency, the Accreditation Council for Graduate Medical Education, and the World Health Organization encourage simulation-based education to improve competency, patient safety, and compliance, thereby supporting wider adoption across healthcare systems.

By offering, Healthcare simulation anatomical models segment accounted for the largest share of the medical simulation market in 2024.

The medical simulation market, by offering, is segmented into medical simulation anatomical models, web-based simulation, healthcare simulation software, and healthcare simulation training services. In 2024, the healthcare simulation anatomical models segment accounted for the largest market share. Their cost-effectiveness compared with live-patient training, combined with the growing popularity of minimally invasive procedures, improvements in surgical techniques, and funding for simulation-based training programs, continues to fuel their popularity and reinforces their leading position in this market segment. Their cost-effectiveness compared with other training procedures continues to fuel their popularity and reinforces their leading position in this market segment. The growing use of minimally invasive procedures and improvements in techniques and funding for simulation-based training programs reinforce their leading position in this segment.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1156

By technology, Virtual patient simulation segment to record the highest CAGR in the medical simulation market.

The medical simulation market is segmented by technology into virtual patient simulation, 3D printing, and procedural rehearsal technology. Among these, the virtual patient simulation segment is expected to register the fastest growth rate during the forecast period. The use of virtual and augmented reality helps learners train and simulate clinical scenarios and decision-making situations in lifelike, realistic settings. For example, MediSim VR and KD Hospital launched India’s first VR nurse training laboratory in June 2024. This clearly shows an increased strategic focus on virtual patient simulation as a revolutionary tool in modern medical education and clinical training.

North America accounted for the largest share of the medical simulation market in 2024.

In 2024, North America led the medical simulation market, driven by relentless investment in mobile simulation technology and rural healthcare simulation training. Among the key highlights of mobile simulation technology development is the June 2024 announcement of the Washington State University Mobile Simulation Program. Additionally, in May 2024, Parkview Health launched the Parkview Health Mobile Medical Training Lab, based in the state of Indiana, US, aimed at addressing a particular gap in the rural landscape through simulation-based learning in remote locations. These initiatives highlight North America’s resolve to rise to the challenge of ensuring increased access to simulation-based learning models.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1156

Top Companies in Medical Simulation Market:

The Top Companies in Medical Simulation Market include CAE Inc. (Canada), Laerdal Medical (Norway), Gaumard Scientific Co. (US), Kyoto Kagaku (Japan), Limbs & Things (UK), Mentice AB (Sweden), Simulab Corporation (US), Simulaids (US), 3B Scientific (Germany), and Surgical Science Sweden AB (Sweden), among others.

Browse Adjacent Markets: Healthcare IT Market Research Reports & Consulting

Related Reports:

Healthcare IT Market – Global Forecast to 2030

Ultrasound Market – Global Forecast to 2030

Laparoscopic Instruments Market – Global Forecast to 2030      

Healthcare Analytics Market – Global Forecast to 2030

Orthopedic Devices Market – Global Forecast to 2030

About MarketsandMarkets 

MarketsandMarkets has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/medical-simulation-market-worth-7-23-billion-by-2030–marketsandmarkets-302682362.html

SOURCE MarketsandMarkets